Methodological Pitfalls in Target Trial Emulations of Incretin Therapeutics and Cancer Endpoints

Chun‐Hsien Yu
Pharmacoepidemiology and Drug Safety · Wiley · 2026-10-28 · DOI: 10.1002/pds.70521

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles